Literature DB >> 11831442

Immediate and delayed leukocyte apoptosis in two models of peritonitis.

J F Kuhn1, C J Godshall, M J Scott, G A Franklin, S A Rowe, J C Peyton, W G Cheadle.   

Abstract

Leukocyte apoptosis is an energy-dependent process that facilitates resolution of the cellular inflammatory response. Levels of apoptosis can be accelerated or inhibited after exposure to various stimuli. To compare apoptosis in transmigrated leukocytes, two models of peritonitis in mice were used that both cause leukocyte influx into the peritoneal cavity: (1) intraperitoneal thioglycollate administration producing a sterile peritonitis and (2) cecal ligation and puncture (CLP) producing a polymicrobial bacterial peritonitis. Samples of blood and peritoneal exudate cells (PEC) were collected at multiple time points after induction of peritonitis. Leukocytes were either fixed immediately to determine an immediate apoptosis level or cultured for 24 h to determine a delayed apoptosis level. Apoptosis was assessed using terminal uridine-triphosphate nick-end labeling (TUNEL) assay, flow cytometry, and confocal microscopy. Leukocyte influx into the peritoneal cavity was confirmed in both models. At all time points, and in both models, there was increased immediate apoptosis in PEC compared with unmanipulated controls and this increase was maximal in CLP after 18 h, although it appeared to remain at a stable level in the sterile peritonitis model by 3 h. There was also an increase in PEC delayed apoptosis at early time points in both models, again maximal at 18 h for CLP, with the levels being significantly higher than the thioglycollate model at 6 h and 18 h. The mice had a relative peripheral neutropenia at 6 h after CLP, but not post thioglycollate injection, and this persisted until 42 h. Lung and liver MPO levels were elevated in CLP but did not increase after thioglycollate. There was no increase in immediate peripheral leukocyte apoptosis in either model, but an increase in delayed peripheral leukocyte apoptosis was observed by 18 h in both models. Peripheral leukocyte CD1lb expression, which is a marker of activation, was also persistently elevated in the CLP model, but not in sterile peritonitis. In conclusion, CLP is a more potent stimulus for apoptosis of leukocytes than their migration to the site of inflammation alone, as occurs in the thioglycollate model. Blood leukocyte apoptosis also appears not to be dependent on CD11b expression, and therefore activation status.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11831442     DOI: 10.1023/a:1012854731259

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  36 in total

Review 1.  Hijacking of apoptotic pathwaysby bacterial pathogens.

Authors:  L Gao; Y Abu Kwaik
Journal:  Microbes Infect       Date:  2000-11       Impact factor: 2.700

2.  Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis.

Authors:  M Keel; U Ungethüm; U Steckholzer; E Niederer; T Hartung; O Trentz; W Ertel
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

Review 3.  Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response.

Authors:  A R Lloyd; J J Oppenheim
Journal:  Immunol Today       Date:  1992-05

4.  Neutrophils are primed for cytotoxicity and resist apoptosis in injured patients at risk for multiple organ failure.

Authors:  W L Biffl; E E Moore; G Zallen; J L Johnson; J Gabriel; P J Offner; C C Silliman
Journal:  Surgery       Date:  1999-08       Impact factor: 3.982

5.  Neutrophils undergo apoptosis following ingestion of Escherichia coli.

Authors:  R W Watson; H P Redmond; J H Wang; C Condron; D Bouchier-Hayes
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

6.  Sepsis-induced apoptosis of the thymocytes in mice.

Authors:  S D Wang; K J Huang; Y S Lin; H Y Lei
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

7.  Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes.

Authors:  S B Brown; J Savill
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

8.  Does hepatocellular injury in sepsis involve apoptosis?

Authors:  A Ayala; T A Evans; I H Chaudry
Journal:  J Surg Res       Date:  1998-05       Impact factor: 2.192

9.  Concomitant increase in neutrophil adhesion to inflammatory peritoneum and remote organs during peritonitis.

Authors:  K Fukatsu; H Saito; I Han; T Inoue; S Furukawa; T Matsuda; S Ikeda; H Yasuhara; T Muto
Journal:  J Surg Res       Date:  1999-02       Impact factor: 2.192

10.  Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators.

Authors:  A Ayala; C D Herdon; D L Lehman; C A Ayala; I H Chaudry
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

View more
  4 in total

1.  Endotoxin inhibits apoptosis but induces primary necrosis in neutrophils.

Authors:  Matthias Turina; Frederick N Miller; Patrick P McHugh; William G Cheadle; Hiram C Polk
Journal:  Inflammation       Date:  2005-02       Impact factor: 4.092

Review 2.  New insights into the role of Plg-RKT in macrophage recruitment.

Authors:  Lindsey A Miles; Shahrzad Lighvani; Nagyung Baik; Caitlin M Parmer; Sophia Khaldoyanidi; Barbara M Mueller; Robert J Parmer
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

3.  AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality.

Authors:  K Doi; X Hu; P S T Yuen; A Leelahavanichkul; H Yasuda; S M Kim; J Schnermann; T E N Jonassen; J Frøkiaer; S Nielsen; R A Star
Journal:  Kidney Int       Date:  2008-03-19       Impact factor: 10.612

4.  Plasminogen inhibits TNFalpha-induced apoptosis in monocytes.

Authors:  Jennifer W Mitchell; Nagyung Baik; Francis J Castellino; Lindsey A Miles
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.